Literature DB >> 8421671

Genomic structure and chromosomal localization of the human deoxycytidine kinase gene.

J J Song1, S Walker, E Chen, E E Johnson, J Spychala, T Gribbin, B S Mitchell.   

Abstract

Deoxycytidine kinase (NTP:deoxycytidine 5'-phosphotransferase, EC 2.7.1.74) is an enzyme that catalyzes phosphorylation of deoxyribonucleosides and a number of nucleoside analogs that are important in antiviral and cancer chemotherapy. Deficiency of this enzyme activity is associated with resistance to these agents, whereas increased enzyme activity is associated with increased activation of such compounds to cytotoxic nucleoside triphosphate derivatives. To characterize the regulation of expression of this gene, we have isolated genomic clones encompassing its entire coding and 5' flanking regions and delineated all the exon/intron boundaries. The gene extends over more than 34 kilobases on chromosome 4 and the coding region is composed of 7 exons ranging in size from 90 to 1544 base pairs (bp). The 5' flanking region is highly G+C-rich and contains four regions that are potential Sp1 binding sites. A 697-bp fragment encompassing 386 bp of 5' upstream region, the 250-bp first exon, and 61 bp of the first intron was demonstrated to promote chloramphenicol acetyltransferase activity in a T-lymphoblast cell line and to have > 6-fold greater activity in a Jurkat T-lymphoblast than in a Raji B-lymphoblast cell line. Our data suggest that these 5' sequences may contain elements that are important for the tissue-specific differences in deoxycytidine kinase expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8421671      PMCID: PMC45676          DOI: 10.1073/pnas.90.2.431

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  The retinoblastoma gene product regulates Sp1-mediated transcription.

Authors:  S J Kim; U S Onwuta; Y I Lee; R Li; M R Botchan; P D Robbins
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

2.  Transcriptional regulation. A closer look at E2F.

Authors:  J R Nevins
Journal:  Nature       Date:  1992-07-30       Impact factor: 49.962

3.  Transfer and expression of plasmids containing human cytomegalovirus immediate-early gene 1 promoter-enhancer sequences in eukaryotic and prokaryotic cells.

Authors:  M G Davis; E S Huang
Journal:  Biotechnol Appl Biochem       Date:  1988-02       Impact factor: 2.431

4.  Complete sequence and structure of the gene for human adenosine deaminase.

Authors:  D A Wiginton; D J Kaplan; J C States; A L Akeson; C M Perme; I J Bilyk; A J Vaughn; D L Lattier; J J Hutton
Journal:  Biochemistry       Date:  1986-12-16       Impact factor: 3.162

Review 5.  Biochemical and cellular pharmacology of cytosine arabinoside.

Authors:  D W Kufe; D R Spriggs
Journal:  Semin Oncol       Date:  1985-06       Impact factor: 4.929

6.  Cell-specific expression of the rat insulin gene: evidence for role of two distinct 5' flanking elements.

Authors:  T Edlund; M D Walker; P J Barr; W J Rutter
Journal:  Science       Date:  1985-11-22       Impact factor: 47.728

7.  Nucleoside kinases in T and B lymphoblasts distinguished by autoradiography.

Authors:  W R Osborne
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

8.  Structure, expression, and mutation of the hypoxanthine phosphoribosyltransferase gene.

Authors:  D W Melton; D S Konecki; J Brennand; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

Review 9.  Regulation of terminal deoxynucleotidyl transferase gene expression in mice and men.

Authors:  M S Coleman; B Yang; D Sorscher
Journal:  Crit Rev Eukaryot Gene Expr       Date:  1992       Impact factor: 1.807

10.  Adenosine deaminase: characterization and expression of a gene with a remarkable promoter.

Authors:  D Valerio; M G Duyvesteyn; B M Dekker; G Weeda; T M Berkvens; L van der Voorn; H van Ormondt; A J van der Eb
Journal:  EMBO J       Date:  1985-02       Impact factor: 11.598

View more
  6 in total

1.  Novel deoxycytidine kinase gene polymorphisms: a population screening study in Caucasian healthy volunteers.

Authors:  M Joerger; T M Bosch; V D Doodeman; J H Beijnen; P H M Smits; J H M Schellens
Journal:  Eur J Clin Pharmacol       Date:  2006-06-24       Impact factor: 2.953

2.  Immunocytochemical detection of deoxycytidine kinase in haematological malignancies and solid tumours.

Authors:  I Hubeek; G J Peters; A J F Broekhuizen; I Talianidis; J Sigmond; B E S Gibson; U Creutzig; G Giaccone; G J L Kaspers
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

3.  Characterization of the deoxycytidine kinase promoter in human lymphoblast cell lines.

Authors:  E H Chen; E E Johnson; S M Vetter; B S Mitchell
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 4.  MCB elements and the regulation of DNA replication genes in yeast.

Authors:  E M McIntosh
Journal:  Curr Genet       Date:  1993-09       Impact factor: 3.886

Review 5.  New targets for pyrimidine antimetabolites for the treatment of solid tumours. 2: Deoxycytidine kinase.

Authors:  V W Ruiz van Haperen; G J Peters
Journal:  Pharm World Sci       Date:  1994-04-15

6.  Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression.

Authors:  Meixian Huang; Takeshi Inukai; Kunio Miyake; Yoichi Tanaka; Keiko Kagami; Masako Abe; Hiroaki Goto; Masayoshi Minegishi; Shotaro Iwamoto; Eiji Sugihara; Atsushi Watanabe; Shinpei Somazu; Tamao Shinohara; Hiroko Oshiro; Koshi Akahane; Kumiko Goi; Kanji Sugita
Journal:  Cancer Med       Date:  2018-02-23       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.